Business Context and Reporting Period
Company: News Corporation (NWSA/NWS)
Filing Type: Form 8-K (Current Report)
Date of Report: June 15, 2021
Reporting Period: Events occurring on June 15, 2021, with agreements effective June 16, 2021, and June 18, 2021.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses on corporate governance and executive compensation agreements.
Material Changes and Agreements
- Extension of Poison Pill Rights: The Company executed a Fourth Amended and Restated Rights Agreement, extending the expiration date of its stockholder rights plan from June 18, 2021, to June 18, 2022. This action was approved by a special committee of independent directors.
- Executive Compensation Update: An Amended and Restated Employment Agreement was entered into with David B. Pitofsky (Executive Vice President, General Counsel, and Chief Compliance Officer), effective July 1, 2021.
Guidance, Outlook, and Management Commentary
The filing contains no forward-looking financial guidance or general business outlook. Management commentary is limited to the rationale for extending the rights plan and the terms of the executive employment agreement.
Executive Compensation Details (David B. Pitofsky)
- Term Extension: Employment term extended to June 30, 2024.
- Compensation Increases:
- Base Salary: Not less than $1,200,000 (approx. 9% increase).
- Target Annual Bonus: Not less than $1,200,000 (approx. 20% increase).
- Target Long-Term Equity: Not less than $1,600,000 (approx. 14% increase).
- At-Risk Compensation: Approximately 70% of target compensation is performance-based.
- Termination Provisions: Significant severance benefits are outlined for termination without cause, including salary continuation, pro-rated bonuses, and equity vesting acceleration.
Investor Verification Checklist
- Verify the full text of the Fourth Amended and Restated Rights Agreement (Exhibit 4.1) to confirm specific trigger events and redemption terms.
- Review the Company's proxy statement or annual report to compare the new compensation targets against historical executive pay trends.
- Confirm the status of the special committee of independent directors that approved the rights plan extension.
- Assess the impact of the extended rights plan on potential takeover scenarios or shareholder activism.